The store will not work correctly when cookies are disabled.
US9428478, TG6-144-2
ID: ALA3972131
PubChem CID: 90276060
Max Phase: Preclinical
Molecular Formula: C20H24N4O2
Molecular Weight: 352.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)c1ccc(NCC(=O)N2CCN(c3ccc(N)cc3)CC2)cc1
Standard InChI: InChI=1S/C20H24N4O2/c1-15(25)16-2-6-18(7-3-16)22-14-20(26)24-12-10-23(11-13-24)19-8-4-17(21)5-9-19/h2-9,22H,10-14,21H2,1H3
Standard InChI Key: KYVDSTYQWDSAQB-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
3.6375 -0.9049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5956 -2.7031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2003 1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2024 2.6932 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.4990 0.7409 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.8007 1.4864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0971 0.7319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0919 -0.7681 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.7903 -1.5136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4939 -0.7591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3890 -1.5230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.6919 -0.7796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9872 -1.5362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9796 -3.0362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.0158 -3.6414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-11.6768 -3.7796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3815 -3.0230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
2 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
10 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 12 1 0
15 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
21 23 1 0
23 24 2 0
24 18 1 0
7 25 1 0
25 26 2 0
26 4 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 352.44 | Molecular Weight (Monoisotopic): 352.1899 | AlogP: 2.23 | #Rotatable Bonds: 5 |
Polar Surface Area: 78.67 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.86 | CX LogP: 1.03 | CX LogD: 1.02 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.64 | Np Likeness Score: -1.46 |
References
1. (2016) Piperazine derivatives, compositions, and uses related thereto, |